|By Marketwired .||
|February 21, 2014 08:15 AM EST||
DAYTONA BEACH, FL -- (Marketwired) -- 02/21/14 -- Quture International, Inc. (OTCQB: QUTR) (Q), the proven and experienced clinical performance and outcomes analytics and solutions company in American healthcare, today announced its plans to participate in the largest health IT industry event of the year, HIMSS Annual Conference & Exhibition, being held at the Orange County Convention Center in Orlando, Florida February 24 - 27, 2014. There Q will introduce for the first time its QualOptima product demonstration and be available at the InterSystems booth on the tradeshow floor at designated times, as well as participating in scheduled product presentations. In addition, Q will be meeting with healthcare providers, focusing on Information Technology (IT) executives in attendance, as well as other vendors to continue to pursue strategic alliances and channel distribution sales, throughout the conference.
Q's QualOptima Connectivity & Analytics System is the optimal strategic technology platform designed to enhance clinical performance and achieve optimal patient outcomes. This first-to-market clinical intelligence software is the complete solution for healthcare providers, payers, employers, and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. QualOptima Version 1, to be first demonstrated at HIMMS, was developed and operates on InterSystems' HealthShare Foundation platform to capture, integrate, aggregate, and analyze patient care data from existing data sources in its innovative second generation database developed in Cache. Even text residing in "unstructured" narrative documents such as discharge summaries, history & physical examinations, operative, radiology and pathology reports, is captured using the iKnow product and other vendor technologies exclusive to Q. Q's exclusive clinical analytics are embedded in InterSystems' powerful analytics DeepSee product, permitting data display and reports from its database reporting system, Zen. InterSystems' DeepSee is embedded in the QualOptima transactional systems to enable users to make decisions based on real-time analysis of structured and unstructured data.
HIMSS is a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS Annual Conference & Exhibition is the industry's largest health IT educational program and exhibition center.
"We are excited about our participation at HIMSS this year. Not only will we be spending time at the InterSystems booth, but also we will be doing first time demonstrations of our ready-to-market full QualOptima Version 1 to HIMSS' audience of healthcare providers and IT executives," commented Landon Feazell, Chairman & CEO of Quture. "This event comes at a pivotal time for the Company as we transition to sales of QualOptima V1 and continue to develop our entire product offering, beginning with the Performance/Peer Review Application, and followed shortly thereafter with the Proctoring Application as announced earlier this week. In addition to the HIMSS platform and other industry-related events, we are focused on showcasing and re-introducing our ready-for-market transformative software and applications still in development to our long-standing relationships in the health sector and to the hundreds of hospitals that have previously engaged Q's predecessor companies."
Feazell added, "In addition to product marketing, we are focused on augmenting Q's management, technology and sales teams to support sales and installations, continued product development and scalability for market rollout. We will be meeting with candidates for the positions of Chief Software Architect, to work with Sherif Elfayoumy, Ph.D., Chief Technology Officer, and Technology/Product Support and Development at Q'Zure, LLC. Additional recruiting of independent contractors needed for on-site product installation and support will also be conducted at the conference. HIMSS is always an energizing, insightful opportunity for our business and right behind it is our next round of strategic meetings at InterSystems' Global Summit in Orlando in late March. We look forward to a great conference and to a steady flow of productive meetings in the week and month ahead."
Healthcare providers, IT executives, as well as vendors, attending HIMSS or in the Orlando area are encouraged to contact Q to schedule one-on-one product demonstrations and to speak personally with Q leadership and staff. For those interested in scheduling a time with Q, please contact Lauren Milner, President of Windmill, directly at 855-652-5310 or by email at firstname.lastname@example.org.
About Quture International, Inc. www.quture.com
Quture International (OTCQB: QUTR) ("Q") is the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare. Q's first-to-market clinical intelligence software is the complete solution for healthcare providers, payers, employers, and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. Q's QualOptima Connectivity & Analytics System empowers value-driven, patient-centered, personalized care focused on real-time and predictive patient management and patient safety, with optimal quality demonstrated by outcomes correlated with resource use, revenue and cost. As an Application Partner of InterSystems Corporation, Q's software operates on their HealthShare strategic technology platform to capture, integrate, aggregate, and analyze data transformed to knowledge in Q's innovative second-generation database. InterSystems (www.intersystems.com) has customers in over 100 countries with 80% of top hospitals in America currently utilizing its technology. Q's core competence and value proposition lies in its embedded evidence-based metrics, clinical content and analytic algorithms developed from over 35 years of measuring performance in hundreds of hospitals, physician organizations and HMO's.
As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions. Q is a Nevada corporation based in Daytona Beach, Florida, and trades on the OTC exchange under the symbol 'QUTR.'
Forward Looking Statements: This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.